Toxic shock syndrome - Revision history

Hoxbox: /* References */

2020-11-16T14:31:59Z

References

← Older revision		Revision as of 14:31, 16 November 2020
Line 72:		Line 72:
	<references/>		<references/>
	[[Category:ID]]		[[Category:ID]]

			==External Links==
			*Internet Bock of Critical Care Toxic Shock Syndrome. https://emcrit.org/ibcc/tss/

Rossdonaldson1: /* Clinical Criteria Staphylococcal toxic shock */

2019-11-16T15:09:33Z

Clinical Criteria Staphylococcal toxic shock

← Older revision		Revision as of 15:09, 16 November 2019
Line 17:		Line 17:
	==Clinical Features==		==Clinical Features==
	===Clinical Criteria Staphylococcal toxic shock===		===Clinical Criteria Staphylococcal toxic shock===
			[[File:PMC5423323 gr2.png\|thumb\|Skin desquamation]]
	*[[Fever]]: temperature >38.9°C<ref name="CDC">CDC. Toxic Shock Syndrome (Other Than Streptococcal). 2011</ref>		*[[Fever]]: temperature >38.9°C<ref name="CDC">CDC. Toxic Shock Syndrome (Other Than Streptococcal). 2011</ref>
	*[[Rash]]: diffuse macular erythroderma		*[[Rash]]: diffuse macular erythroderma

Rossdonaldson1: /* Background */

2019-11-16T14:45:49Z

Background

← Older revision		Revision as of 14:45, 16 November 2019
Line 1:		Line 1:
	==Background==		==Background==
	*Staphylococcal (Staph aureus) and Streptococcal (Type A strep: Step. pyogenes)types		*Staphylococcal ([[Staph aureus]]) and Streptococcal ([[Type A strep]]: Step. pyogenes) types
	*1-2/100,000 cases/year		*1-2/100,000 cases/year
	*[[S. aureus]] strain that produces toxic shock syndrome toxin-1 (superantigen) is the most common cause		*[[S. aureus]] strain that produces toxic shock syndrome toxin-1 (superantigen) is the most common cause

Ostermayer at 18:24, 23 April 2019

2019-04-23T18:24:58Z

← Older revision		Revision as of 18:24, 23 April 2019
Line 16:		Line 16:

	==Clinical Features==		==Clinical Features==
	Clinical Criteria Staphylococcal toxic shock<ref name="CDC">CDC. Toxic Shock Syndrome (Other Than Streptococcal). 2011</ref>		===Clinical Criteria Staphylococcal toxic shock===
	*[[Fever]]: temperature >38.9°C		*[[Fever]]: temperature >38.9°C<ref name="CDC">CDC. Toxic Shock Syndrome (Other Than Streptococcal). 2011</ref>
	*[[Rash]]: diffuse macular erythroderma		*[[Rash]]: diffuse macular erythroderma
	*[[Hypotension]]: systolic blood pressure <90 mm Hg (adults) or <5th percentile for age (children younger than 16 years), or orthostatic hypotension, dizziness, or syncope		*[[Hypotension]]: systolic blood pressure <90 mm Hg (adults) or <5th percentile for age (children younger than 16 years), or orthostatic hypotension, dizziness, or syncope
Line 30:		Line 30:
	*Desquamation: One to 2 weeks after the onset of illness (typically palms and soles)		*Desquamation: One to 2 weeks after the onset of illness (typically palms and soles)

	Clinical Criteria Streptococcal Toxic Shock ~~[2]~~		===Clinical Criteria Streptococcal Toxic Shock===
	*Hypotension: systolic blood pressure <90 (adult) or <5th percentile for age (children younger than 16 years)		*Hypotension: systolic blood pressure <90 (adult) or <5th percentile for age (children younger than 16 years)<ref>Liang SY. Toxic Shock Syndromes. In: Tintinalli JE, Stapczynski J, Ma O, Yealy DM, Meckler GD, Cline DM. eds. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, 8e New York, NY: McGraw-Hill; 2016. http://accessmedicine.mhmedical.com/content.aspx?bookid=1658&sectionid=109435589. Accessed November 29, 2017.</ref>
	*Multiorgan involvement(>2 organ systems):		*Multiorgan involvement(>2 organ systems):
	**Skin: generalized erythematous macular rash that may desquamate		**Skin: generalized erythematous macular rash that may desquamate
Line 70:		Line 70:
	==References==		==References==
	<references/>		<references/>
	2.Liang SY. Toxic Shock Syndromes. In: Tintinalli JE, Stapczynski J, Ma O, Yealy DM, Meckler GD, Cline DM. eds. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, 8e New York, NY: McGraw-Hill; 2016. http://accessmedicine.mhmedical.com/content.aspx?bookid=1658&sectionid=109435589. Accessed November 29, 2017.
	[[Category:ID]]		[[Category:ID]]

Kxl328: /* Risk Factors */

2018-10-18T00:37:36Z

Risk Factors

← Older revision		Revision as of 00:37, 18 October 2018
Line 9:		Line 9:
	===Risk Factors===		===Risk Factors===
	*Postop patients		*Postop patients
	*[[Epistaxis\|~~nasal~~ packing]]		*[[Epistaxis\|Nasal packing]]
	*[[Abscess]]		*[[Abscess]]
	*[[Burns]]		*[[Burns]]

Iwm5010: /* Clinical Features */

2017-11-29T23:45:51Z

Clinical Features

← Older revision		Revision as of 23:45, 29 November 2017
Line 30:		Line 30:
	*Desquamation: One to 2 weeks after the onset of illness (typically palms and soles)		*Desquamation: One to 2 weeks after the onset of illness (typically palms and soles)

	Clinical Criteria Streptococcal Toxic Shock		Clinical Criteria Streptococcal Toxic Shock [2]
	*Hypotension: systolic blood pressure <90 (adult) or <5th percentile for age (children younger than 16 years)		*Hypotension: systolic blood pressure <90 (adult) or <5th percentile for age (children younger than 16 years)
	*Multiorgan involvement(>2 organ systems):		*Multiorgan involvement(>2 organ systems):

Iwm5010: /* Evaluation */

2017-11-29T23:45:05Z

Evaluation

← Older revision		Revision as of 23:45, 29 November 2017
Line 51:		Line 51:
	*Probable case meets 4-5 clinical criteria plus lab criteria		*Probable case meets 4-5 clinical criteria plus lab criteria

	Case definition for Streptococcal Toxic Shock Syndrome		Case definition for Streptococcal Toxic Shock Syndrome[2]
	*Lab Criteria		*Lab Criteria
	**Isolation of group A Streptoccocus		**Isolation of group A Streptoccocus

Iwm5010: /* References */

2017-11-29T23:44:19Z

References

← Older revision		Revision as of 23:44, 29 November 2017
Line 70:		Line 70:
	==References==		==References==
	<references/>		<references/>
	Tintinalli, ~~Judith E.~~,, ~~et al~~. ~~Tintinalli's~~ Emergency Medicine: A Comprehensive Study Guide~~. Eighth edition.~~ New York: McGraw-Hill ~~Education~~, ~~2016~~.		2.Liang SY. Toxic Shock Syndromes. In: Tintinalli JE, Stapczynski J, Ma O, Yealy DM, Meckler GD, Cline DM. eds. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, 8e New York, NY: McGraw-Hill; 2016. http://accessmedicine.mhmedical.com/content.aspx?bookid=1658&sectionid=109435589. Accessed November 29, 2017.
	[[Category:ID]]		[[Category:ID]]

Iwm5010: /* References */

2017-11-29T23:41:06Z

References

← Older revision		Revision as of 23:41, 29 November 2017
Line 70:		Line 70:
	==References==		==References==
	<references/>		<references/>
			Tintinalli, Judith E.,, et al. Tintinalli's Emergency Medicine: A Comprehensive Study Guide. Eighth edition. New York: McGraw-Hill Education, 2016.
	[[Category:ID]]		[[Category:ID]]

Iwm5010: /* Management */

2017-11-29T23:34:01Z

Management

← Older revision		Revision as of 23:34, 29 November 2017
Line 60:		Line 60:
	==Management==		==Management==
	*Antibiotics:		*Antibiotics:
	**Staphylococcal:[[Clindamycin]] (suppresses toxin synthesis), plus an anti-staph penicillin (e.g. [[Oxacillin]] or [[Nafcillin]]) or [[Vancomycin]]/Linezolid for MRSA		**Staphylococcal: [[Clindamycin]] (suppresses toxin synthesis), plus an anti-staph penicillin (e.g. [[Oxacillin]] or [[Nafcillin]]) or [[Vancomycin]]/Linezolid for MRSA
	**Streptococcal: Clindamycin and Piperacillin-tazobactam or Meropenem		**Streptococcal: Clindamycin and Piperacillin-tazobactam or Meropenem